Bespoke research support for cancer immunotherapies (immuno oncology)

“We empower our clients with extensive domain expertise in the field of oncology therapy and offer customised research offerings across the oncology value chain”

CONNECT WITH AN EXPERT

Cancer immunotherapy (CIT) is a major pillar of cancer treatment, improving the prognosis of patients with a broad variety of haematological and solid malignancies. The two main drivers are checkpoint inhibitors (CPIs) and chimeric antigen receptor (CAR) T cells. CIT is a thriving field likely to become key in the fight against cancer.

Leading pharma companies including Roche, AstraZeneca, Bristol Myers Squibb, Pfizer and Merck are focusing on clinical trials with immune CPIs and CAR-T cell therapies across patient segments and tumour indications to stay competitive and meet rising demand for these therapies.

The increasing need for personalised therapies, the growing incidence of cancer, rising healthcare expenditure and recent approvals in PD-1 and PD-L1 inhibitors and CAR-T cell therapies will likely drive growth in the global cancer immunotherapeutics market.

Explore how our healthcare experts can provide support on the latest trends and emerging immunotherapies, current limitations, opportunities, developments and growth areas in this space

BENEFITS AND IMPACT

Domain expertise across the life sciences and healthcare ecosystem, with specialised expertise across therapeutic areas including oncology segments and rare diseases

Real-world expertise from solving challenges of 5 of the top 8 global pharmaceutical giants, meeting their strategic and business research needs

Actionable insights providing direct, meaningful action items for optimised decision making

Dedicated team that understands the specific needs of the life sciences sector, shares customised output and works towards building long-term client relationships

Flexible engagement models supporting changing requirements and dynamic market conditions to scale up or down, based on client requirement

Improved savings through operational cost savings, a dedicated team and automation

100% data confidentiality with industry-benchmarked SOC2 compliance

Cross-divisional support providing on-demand data analytics, financial services, deal tracking, commercial due diligence, M&A analysis and design and editorial support

Our offering

Strategy research and due diligence projects

Tap to flip

Our extensive research capabilities can help you efficiently manage increased demand

  • Life-cycle management strategy

  • Opportunity assessment and market attractiveness

  • Indication prioritisation

  • Product launch strategies

  • Licensing and acquisition

  • Market entry and due diligence

  • Pricing and reimbursement strategies

  • Technology or partner scouting

Support with pricing and drug launch strategies

Tap to flip

Our research team provides assistance with these strategies and with in-depth impact analysis

  • Global pricing strategy

  • Pre-launch planning and launch strategies

  • Drug pricing, reimbursement and market access analysis

  • Market sizing and forecasting

  • Market assessment and dynamics

  • Social media analytics

Market and competitive intelligence in the field of oncology therapy

Tap to flip

We manage the bulk of your research, enabling you to focus on core areas

  • Competitive intelligence and oncology pipeline analysis

  • Daily/weekly alerts tracking assets/competitors

  • KOL identification and primary research

  • Competitor profiling and benchmarking

  • Market assessment and sizing

  • Commercial and scientific conference coverage

  • Clinical trial site selection

  • Literature searches and newsletters

Support with regulatory policies in healthcare

Tap to flip

We have been keeping abreast of changes in regulation and help you create a master report along with daily/weekly alerts tracking changes

  • Regulatory approval in different countries

  • Regulatory requirements for clinical trials

  • Pricing and reimbursement policies

  • Patient access programmes

  • Macroeconomic policies of different countries

Thank you for sharing your details

Share this on